Stock Analysis

Asian Market Insights: Jiangxi Rimag Group And 2 Stocks That May Be Trading Below Estimated Value

As global markets navigate the complexities of economic data releases and policy decisions, Asia's stock markets are capturing attention with their unique challenges and opportunities. In this environment, identifying undervalued stocks, such as Jiangxi Rimag Group and others potentially trading below estimated value, requires a focus on strong fundamentals and resilience amidst fluctuating market conditions.

Advertisement

Top 10 Undervalued Stocks Based On Cash Flows In Asia

NameCurrent PriceFair Value (Est)Discount (Est)
Zhejiang Leapmotor Technology (SEHK:9863)HK$52.25HK$102.8149.2%
Sinolong New Materials (SZSE:301565)CN¥28.12CN¥55.5449.4%
PharmaResearch (KOSDAQ:A214450)₩450500.00₩884165.7049%
Nippon Thompson (TSE:6480)¥703.00¥1403.7349.9%
Ningxia Building Materials GroupLtd (SHSE:600449)CN¥13.34CN¥26.2349.1%
New Zealand King Salmon Investments (NZSE:NZK)NZ$0.196NZ$0.3949.2%
LianChuang Electronic TechnologyLtd (SZSE:002036)CN¥10.10CN¥20.1749.9%
Jiangxi Rimag Group (SEHK:2522)HK$17.24HK$34.2549.7%
Beijing Beimo High-tech Frictional MaterialLtd (SZSE:002985)CN¥28.15CN¥56.2550%
ASE Technology Holding (TWSE:3711)NT$215.00NT$426.7749.6%

Click here to see the full list of 279 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let's explore several standout options from the results in the screener.

Jiangxi Rimag Group (SEHK:2522)

Overview: Jiangxi Rimag Group Co., Ltd. invests in and operates medical imaging centers in China, with a market cap of HK$6.90 billion.

Operations: The company generates revenue primarily from its medical labs and research segment, amounting to CN¥813.93 million.

Estimated Discount To Fair Value: 49.7%

Jiangxi Rimag Group is trading at HK$17.24, significantly below its estimated fair value of HK$34.25, indicating potential undervaluation based on cash flows. The company's revenue is projected to grow 24.3% annually, surpassing the Hong Kong market's average growth rate of 8.5%. Recent strategic alliances in AI-based medical imaging have led to a RMB 10 million commercialization contract, enhancing its data business competitiveness and supporting sustainable development through innovative collaborations.

SEHK:2522 Discounted Cash Flow as at Nov 2025
SEHK:2522 Discounted Cash Flow as at Nov 2025

Yangtze Optical Fibre And Cable Limited (SEHK:6869)

Overview: Yangtze Optical Fibre And Cable Joint Stock Limited Company produces and sells optical fiber preforms rods, optical fiber, and optical fiber cables both in China and internationally, with a market cap of HK$47.41 billion.

Operations: The company's revenue segments include the production and sale of optical fiber preforms rods, optical fiber, and optical fiber cables both domestically and abroad.

Estimated Discount To Fair Value: 22.9%

Yangtze Optical Fibre And Cable Limited is trading at HK$33.72, over 20% below its estimated fair value of HK$43.73, highlighting potential undervaluation based on cash flows. Despite a recent decline in profit margins and net income for the nine months ending September 2025, the company's earnings are forecast to grow significantly at 45.3% annually, outpacing the Hong Kong market average. However, share price volatility remains a concern for investors.

SEHK:6869 Discounted Cash Flow as at Nov 2025
SEHK:6869 Discounted Cash Flow as at Nov 2025

Hanshow Technology (SZSE:301275)

Overview: Hanshow Technology Co. Ltd, with a market cap of CN¥22.60 billion, specializes in providing electronic shelf labeling solutions.

Operations: Hanshow Technology's revenue is primarily generated from its Electric Equipment segment, amounting to CN¥4.14 billion.

Estimated Discount To Fair Value: 38.3%

Hanshow Technology is trading at CN¥53.5, significantly below its estimated fair value of CN¥86.71, suggesting potential undervaluation based on cash flows. Despite a decline in net income for the nine months ending September 2025, earnings are forecast to grow substantially at 31.6% annually, surpassing the Chinese market average. Recent strategic collaborations and a share repurchase program highlight efforts to enhance digitalization and shareholder value amidst current financial challenges.

SZSE:301275 Discounted Cash Flow as at Nov 2025
SZSE:301275 Discounted Cash Flow as at Nov 2025

Make It Happen

Searching for a Fresh Perspective?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com